| Source: |
| Type: |
| GLS - Glutaminase Abbreviation: GLS, GLS1, Kidney-Type Glutaminase Alternative Names: KGA, GAC Type: Mitochondrial metabolic enzyme / glutamine metabolism enzyme / glutaminolysis regulator Function: GLS catalyzes the conversion of glutamine to glutamate and ammonia, providing the first major enzymatic step of glutaminolysis. Glutamate can subsequently be converted to α-ketoglutarate to replenish the TCA cycle and can also support glutathione synthesis, amino-acid metabolism, nucleotide synthesis, lipid synthesis, and cellular redox control. Cancer: ↑ GLS expression and activity are increased in many cancers and support glutamine-dependent proliferation, energy production, anabolic metabolism, redox homeostasis, survival, and treatment resistance. Favorable Direction in Cancer: ↓ GLS expression or activity is generally favorable in glutamine-dependent cancers and can reduce glutaminolysis, TCA-cycle replenishment, glutathione production, and cancer-cell survival. Pathway Relationship: GLS ↑ → glutaminolysis ↑ → glutamate ↑ → α-ketoglutarate/TCA-cycle anaplerosis ↑ and glutathione synthesis ↑. Interpretation Note: GLS should be distinguished from GLS2. GLS generally has a stronger tumor-promoting association, whereas GLS2 can function as either a tumor promoter or tumor suppressor depending on cancer type. |
| 975- | Est, | Estrogen inhibits autophagy and promotes growth of endometrial cancer by promoting glutamine metabolism |
| - | vitro+vivo, | UEC, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:0 prod#:% Target#:127 State#:% Dir#:2
wNotes=0 sortOrder:rid,rpid